Who owns NOVABAY PHARMACEUTICALS INC?

Tip: Access positions for across all investors

Analyze quarterly positions in Novabay Pharmaceuticals with up to 7 years of data, all consolidated into one spreadsheet

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Top investors of Novabay Pharmaceuticals stock

Who bought or sold NOVABAY PHARMACEUTICALS INC this quarter?

Fund or Company Name Shares Held Valued At Change in Shares As Of Actions
UBS Group 221k $23k 2496% Mar 2024
 View chart
Two Sigma Securities 149k $16k 836% Mar 2024
 View chart
Geode Capital Management 25k $2.6k 0% Mar 2024
 View chart
Tower Research Capital 15k $1.6k 36% Mar 2024
 View chart
Vanguard Group 14k $1.4k 0% Mar 2024
 View chart
Zacks Investment Management 10k $1.0k 100% Mar 2024
 View chart
Morgan Stanley 158.00 $17.000800 0% Mar 2024
 View chart
Bank of America Corporation 86.00 $9.004200 0% Mar 2024
 View chart
Wells Fargo & Company 51.00 $4.998000 2% Mar 2024
 View chart
Advisor Group Holdings 37.00 $3.999700 0% Mar 2024
 View chart
Ronald Blue Trust 37.00 $3.999700 0% Mar 2024
 View chart
Royal Bank of Canada 15.00 $0 0% Mar 2024
 View chart
Northwestern Mutual Wealth Management Company 12.00 $0.999600 100% Mar 2024
 View chart
Addison Advisors 4.00 $1.000000 0% Mar 2024
 View chart

Who sold out of Novabay Pharmaceuticals?

Fund or Company Name Date Sold Shares Held Valued At
Virtu Financial Dec 2023 65k $13k
Hudson Bay Capital Management Dec 2023 54k $11k
Citadel Advisors Dec 2023 37k $7.5k
Hrt Financial Dec 2023 17k $3.0k
BlackRock Sep 2023 20.00 $9.000000